COVID-19 and Tuberculosis Vaccine

Authors

  • Giulio Tarro T.&L. de Beaumont Bonelli Foundation for Cancer Research, Naples, Italy

DOI:

https://doi.org/10.14738/bjhmr.104.15334

Keywords:

BCG vaccine, COVID-19, non-EU citizens, health care, SARS

Abstract

In Italy non-EU citizens were not recovered in the hospitals during the COVID-19 epidemy. They are all covered by a tuberculosis vaccine which is part of a coverage protocol provided by the Local Healthy Unit. In the Sierra de Ecuador, normally everyone received TB vaccination: the cases of manifest infection of COVID-19 are very few. In Australia tests on 4 thousand doctors and nurses with the tuberculosis vaccine took place. Lately BCG to protect against COVID-19 in health care workers has been used by many authors in clinical trials.

Downloads

Published

2023-08-26

How to Cite

Tarro, G. (2023). COVID-19 and Tuberculosis Vaccine. British Journal of Healthcare and Medical Research, 10(4), 228–230. https://doi.org/10.14738/bjhmr.104.15334

Issue

Vol. 10 No. 4 (2023): British Journal of Healthcare and Medical Research

Section

Original Articles

License

Copyright (c) 2023 Giulio Tarro

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

1 2 > >>